Ironwood Pharmaceuticals (IRWD) Change in Acquisitions & Divestments (2016 - 2018)
Ironwood Pharmaceuticals' Change in Acquisitions & Divestments history spans 9 years, with the latest figure at $19.9 million for Q4 2018.
- On a quarterly basis, Change in Acquisitions & Divestments fell 28.48% to $19.9 million in Q4 2018 year-over-year; TTM through Dec 2018 was $99.2 million, a 71.41% decrease, with the full-year FY2018 number at $99.2 million, down 71.41% from a year prior.
- Change in Acquisitions & Divestments hit $19.9 million in Q4 2018 for Ironwood Pharmaceuticals, up from $16.8 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for IRWD hit a ceiling of $212.0 million in Q3 2015 and a floor of $13.9 million in Q2 2018.
- Historically, Change in Acquisitions & Divestments has averaged $65.0 million across 5 years, with a median of $48.6 million in 2018.
- Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 699.65% in 2015 and later tumbled 89.8% in 2016.
- Tracing IRWD's Change in Acquisitions & Divestments over 5 years: stood at $52.5 million in 2014, then surged by 303.99% to $212.0 million in 2015, then crashed by 84.23% to $33.4 million in 2016, then dropped by 16.99% to $27.8 million in 2017, then fell by 28.48% to $19.9 million in 2018.
- Business Quant data shows Change in Acquisitions & Divestments for IRWD at $19.9 million in Q4 2018, $16.8 million in Q3 2018, and $13.9 million in Q2 2018.